| ||
Adcock Ingram buys Cosme Farma's drug portfolio for $86M VC Circle South Africa's Adcock Ingram has acquired the pharmaceutical brands of privately held Cosme Farma Laboratories Ltd for Rs 480 crore ($86 million). The all-cash deal will see the acquisition of Cosme Pharma's portfolio in areas like dermatology and ... See all stories on this topic » | ||
Pharmaceutical Packaging is at the Centre Stage of Pharma Manufacturing! MarketWatch (press release) India is one the largest producer of pharmaceuticals, and hence, the importance of packaging cannot be understated. With the US and Europe looking to boost quality and safety of the medicines entering their markets, it is the need of the hour for ... See all stories on this topic » | ||
Oramed Pharmaceuticals Granted 2nd Patent in New Zealand; 3rd Patent for ... MarketWatch (press release) Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs and vaccines currently delivered via injection. Established in 2006, Oramed's technology is based on over 25 years of research by top research scientists ... See all stories on this topic » | ||
FDI in pharma: PMO sends missive to finance, industry ministries seeking ... Economic Times The PMO has shot off letters to finance and industry ministries seeking a progress report on implementation of the changes in FDI in the pharmaceutical sector. See all stories on this topic » | ||
Rising Pharmaceuticals launches carisoprodol and Aspirin tablets pharmabiz.com Rising Pharmaceuticals launches carisoprodol and Aspirin tablets. See all stories on this topic » | ||
| ||
Ironwood Pharmaceuticals to Host Second Quarter 2012 Investor Update Call MarketWatch (press release) CAMBRIDGE, Mass., Jul 10, 2012 (BUSINESS WIRE) -- Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) today announced it will host its second quarter 2012 investor update conference call and webcast at 8:30 a.m. Eastern Time on Tuesday, July 17, 2012. See all stories on this topic » | ||
La Jolla Pharmaceutical Company to Webcast, Live, at ... Sacramento Bee PRNewswire/ -- La Jolla Pharmaceutical Company (OTCQB: LJPC) today announced that their Chief Executive Officer, George F. Tidmarsh, MD, PhD, will present at RetailInvestorConferences.com. See all stories on this topic » | ||
|
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment